These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27418972)

  • 1. Targeting T cells to treat atherosclerosis: odyssey from bench to bedside.
    Bullenkamp J; Dinkla S; Kaski JC; Dumitriu IE
    Eur Heart J Cardiovasc Pharmacother; 2016 Jul; 2(3):194-9. PubMed ID: 27418972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances on CD4
    Grönberg C; Nilsson J; Wigren M
    Eur J Pharmacol; 2017 Dec; 816():58-66. PubMed ID: 28457923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell-based therapies for atherosclerosis.
    Ketelhuth DF; Gisterå A; Johansson DK; Hansson GK
    Curr Pharm Des; 2013; 19(33):5850-8. PubMed ID: 23438952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells as a new therapeutic target for atherosclerosis.
    Ou HX; Guo BB; Liu Q; Li YK; Yang Z; Feng WJ; Mo ZC
    Acta Pharmacol Sin; 2018 Aug; 39(8):1249-1258. PubMed ID: 29323337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.
    Sharma M; Schlegel MP; Afonso MS; Brown EJ; Rahman K; Weinstock A; Sansbury BE; Corr EM; van Solingen C; Koelwyn GJ; Shanley LC; Beckett L; Peled D; Lafaille JJ; Spite M; Loke P; Fisher EA; Moore KJ
    Circ Res; 2020 Jul; 127(3):335-353. PubMed ID: 32336197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T cells in atherosclerosis: regulation by platelets.
    Li N
    Thromb Haemost; 2013 Jun; 109(6):980-90. PubMed ID: 23446374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice.
    Ji Q; Meng K; Yu K; Huang S; Huang Y; Min X; Zhong Y; Wu B; Liu Y; Nie S; Zhang J; Zhou Y; Zeng Q
    Sci Rep; 2017 Jun; 7(1):3310. PubMed ID: 28607385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis as an inflammatory disease.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
    Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination Strategies and Immune Modulation of Atherosclerosis.
    Nilsson J; Hansson GK
    Circ Res; 2020 Apr; 126(9):1281-1296. PubMed ID: 32324498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of microRNA-155 exerts an anti-inflammatory effect on CD4+ T cell-mediated inflammatory response in the pathogenesis of atherosclerosis.
    Zheng J; Wang W; Hong T; Yang S; Shen J; Liu C
    Acta Biochim Biophys Sin (Shanghai); 2020 Jun; 52(6):654-664. PubMed ID: 32372074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint inhibition alters the inflammatory cell composition of human coronary artery atherosclerosis.
    Newman JL; Stone JR
    Cardiovasc Pathol; 2019; 43():107148. PubMed ID: 31518915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease.
    Yamashita T; Sasaki N; Kasahara K; Hirata K
    J Cardiol; 2015 Jul; 66(1):1-8. PubMed ID: 25744783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
    McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
    Front Immunol; 2021; 12():660506. PubMed ID: 34093549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating atherosclerosis with regulatory T cells.
    Foks AC; Lichtman AH; Kuiper J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):280-7. PubMed ID: 25414253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune system and atherosclerotic disease: heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis.
    Shimada K
    Circ J; 2009 Jun; 73(6):994-1001. PubMed ID: 19430164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4
    Wan Q; Liu Z; Yang M; Wu J
    Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting B cells in atherosclerosis: closing the gap from bench to bedside.
    Tsiantoulas D; Sage AP; Mallat Z; Binder CJ
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):296-302. PubMed ID: 25359862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
    George J
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice.
    Kita T; Yamashita T; Sasaki N; Kasahara K; Sasaki Y; Yodoi K; Takeda M; Nakajima K; Hirata K
    Cardiovasc Res; 2014 Apr; 102(1):107-17. PubMed ID: 24403315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.